Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells
Open Access
- 24 April 2009
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 23 (9) , 2996-3006
Abstract
Compartmentalization within eukaryotic cells hinders the efficient delivery of therapeutic agents to the cell nucleus. Here we describe novel multifunctional DNA carriers (MDCs) that self‐assemble with DNA to form structured nanoparticles that possess virus‐like functions for cellular trafficking. MDCs contain, in fusion, the DNA‐compacting sperm chromatin component protamine, α‐melanocyte‐stimulating hormone for cell‐targeted internalization, the endosometranslocation domain of diphtheria toxin, and an optimized nuclear localization sequence to confer recognition by the nuclear import machinery. The structure of the MDC‐DNA particles was examined using atomic force microscopy, and the functionality of each domain assessed using in vitro techniques, including a reconstituted nuclear transport assay in semi‐intact cells relying on the use of quantitative confocal laser scanning microscopy. The nanoparticles were internalized in cell‐specific fashion and subsequently exited the endosome into the cytoplasm. Notably, the nanoparticles interact with cellular nuclear transport proteins as shown in direct binding assays and are actively trafficked into the cell nucleus of nondividing cells, resulting in 3‐ to 4‐fold higher reporter gene expression in growth‐arrested human embryonic kidney cells, as well as lower cytotoxicity, than lipid and polyethyleneimine vectors. The importance of each functional domain was examined by comparing MDCs with different domain compositions as controls, as well as using antibodies to block particular pathways. MDCs that utilize cellular signaling pathways have enormous potential to safely and efficiently deliver therapeutic transgenes into the nucleus of nondividing cells.—Glover, D. J., Ng, S. M., Mechler, A., Martin, L. L., Jans, D. A. Multifunctional protein nanocarriers for targeted nuclear gene delivery in nondividing cells. FASEBJ. 23, 2996–3006 (2009). www.fasebj.orgKeywords
Funding Information
- National Health and Medical Research Council (284205)
This publication has 29 references indexed in Scilit:
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Behavior of the N-Terminal Helices of the Diphtheria Toxin T Domain during the Successive Steps of Membrane InteractionBiochemistry, 2007
- Artificial viruses: a nanotechnological approach to gene deliveryNature Reviews Drug Discovery, 2006
- Chromosome architecture in the decondensing human sperm nucleusJournal of Cell Science, 2005
- Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: The use of a nuclear transfer scoreFEBS Letters, 2005
- Towards safe, non-viral therapeutic gene expression in humansNature Reviews Genetics, 2005
- Characterization of diphtheria toxin's catalytic domain interaction with lipid membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2004
- Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma markerBritish Journal of Cancer, 2002
- Protamine-Induced Condensation and Decondensation of the Same DNA MoleculeScience, 1999
- AFM analysis of DNA-protamine complexes bound to micaNucleic Acids Research, 1997